Navigation Links
Cadence Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Date:11/15/2011

olicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About Cadence Pharmaceuticals, Inc.

Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary products principally for use in the hospital setting.  

Forward-Looking Statements

Statements included in this press release that are not a description of historical facts are forward-looking statements. Words such as "plans," "believes," "expects," "anticipates," and "will," and similar expressions, are intended to identify forward-looking statements, and are based on Cadence's current beliefs and expectations. Such statements include, but are not limited to, statements regarding the completion, timing and size of the public offering, and the expected net proceeds therefrom.  Actual results may differ materially from those set forth in this press release due to the risks and uncertainties, including, without limitation, those associated with market conditions and the satisfaction of customary closing conditions related to the public offering, as well as those inherent in Cadence's business and finances in general, including the risks detailed in Cadence's prior press releases as well as in Cadence's periodic and other public filings with the SEC.  You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.  All forward-looking statements are qualified in their entirety by this cautionary statement and Cadence undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof.  This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.  Contact:

William R. LaRue

Kelli FranceSVP & Chief Financial Officer


'/>"/>
SOURCE Cadence Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
2. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
3. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008
4. Cadence Pharmaceuticals Updates Omigard(TM) Clinical Timeline
5. Cadence Pharmaceuticals Reports Third Quarter 2008 Financial Results and Provides Clinical Development Programs Update
6. Cadence Pharmaceuticals Submits Acetavance New Drug Application for the Treatment of Acute Pain and Fever
7. Cadence Pharmaceuticals to Webcast October 7th Analyst Day
8. Cadence Pharmaceuticals CEO Ted Schroeder to Present at the BIOCOM Investor Conference in San Diego on October 27, 2009
9. Cadence Pharmaceuticals CEO Ted Schroeder To Present at the Oppenheimer 20th Annual Healthcare Conference in New York City on November 4, 2009
10. Cadence Pharmaceuticals Announces FDA Extends New Drug Application Review for Intravenous Acetaminophen by Three Months
11. Oxford Finance Corporation Leads $30 Million Secured Loan Facility for Cadence Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 An experimental drug designed ... a viable first treatment for anemia of inflammation, according to ... treatment published online today in Blood , ... (ASH).    Anemia is a condition that occurs ... not function properly. When an individual has anemia, the body ...
(Date:8/27/2014)... 27, 2014 Kewaunee Scientific Corporation (Nasdaq: ... increased its quarterly cash dividend by 9% to twelve ... share, beginning with the dividend payable on September 22, ... business on September 8, 2014. About ... Kewaunee Scientific Corporation is a recognized global leader in ...
(Date:8/27/2014)... and NINGBO, China , Aug. ... Ningbo Menovo Pharmaceutical Co., Ltd, ("Menovo") today announced they ... of generic pharmaceuticals, primarily targeting the United ... agreement, Amerigen and Menovo will jointly develop products for ... . Menovo will be responsible for manufacturing API ...
Breaking Medicine Technology:Drug Represents First Potential Treatment for Common Anemia 2Drug Represents First Potential Treatment for Common Anemia 3Amerigen Pharmaceuticals Limited and the Ningbo Menovo Pharmaceutical Co., Ltd, today announced they had entered into a collaboration agreement regarding the development of generic pharmaceuticals, primarily targeting the United States market 2
... announces that a new market research report is ... Test-Volume-Sales-Forecasts-and-Supplier-Shares-by-Country.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic title=,The 2011 Prostatic Acid Phosphatase Testing Market: ... Test Volume, Sales Forecasts and Supplier Shares ... US, Europe, Japan ...
... /PRNewswire-Asia-FirstCall/ -- Dehaier Medical Systems Ltd. (Nasdaq: ... emerging leader in the development, assembly, marketing and sale ... today announced its financial results for the third quarter ... Third Quarter 2011 Financial Highlights   ...
Cached Medicine Technology:The 2011 Prostatic Acid Phosphatase Testing Market: US, Europe, Japan 2The 2011 Prostatic Acid Phosphatase Testing Market: US, Europe, Japan 3The 2011 Prostatic Acid Phosphatase Testing Market: US, Europe, Japan 4The 2011 Prostatic Acid Phosphatase Testing Market: US, Europe, Japan 5Dehaier Medical Announces Record Third Quarter 2011 Financial Results 2Dehaier Medical Announces Record Third Quarter 2011 Financial Results 3Dehaier Medical Announces Record Third Quarter 2011 Financial Results 4Dehaier Medical Announces Record Third Quarter 2011 Financial Results 5Dehaier Medical Announces Record Third Quarter 2011 Financial Results 6Dehaier Medical Announces Record Third Quarter 2011 Financial Results 7Dehaier Medical Announces Record Third Quarter 2011 Financial Results 8Dehaier Medical Announces Record Third Quarter 2011 Financial Results 9Dehaier Medical Announces Record Third Quarter 2011 Financial Results 10
(Date:8/27/2014)... (PRWEB) August 28, 2014 A St. ... Danis & Lowe reports that the C.R. Bard ... thousands of consolidated transvaginal mesh lawsuits, recently filed a ... #136 pertains to the pretrial discovery process, and more ... sensitive evidence. , Carey Danis & Lowe is a ...
(Date:8/27/2014)... (PRWEB) August 28, 2014 Recently, BambooIndustry.com, an ... items, has announced that new bamboo panels are ... now providing deep discounts for clients worldwide. All people that ... a discounted rate, from 10 to 30 percent off. ... the new panels. “At the moment, all our new and ...
(Date:8/27/2014)... West Palm Beach, Florida (PRWEB) August 28, 2014 ... star Kevin Harrington, Chairman of As Seen On ... also known as “The Millionaire Maker”. as Excelerate attendees ... real sharks, and will have the ability to pitch ... team of World Renowned Business Experts and Millionaire Mentors ...
(Date:8/27/2014)... (PRWEB) August 28, 2014 Delta, a ... recently added several practical Cat D7R Dozers to its ... company’s senior spokesman has announced that all these items ... this promotion is to expand Delta’s market share in ... proud to launch the special offer; he has much ...
(Date:8/27/2014)... August 27, 2014 Taking its popular obstacle ... Steele Creek YMCA will host its largest crowd at ... Saturday, September 13 at YMCA Camp Thunderbird . ... divisions: adult, youth and teams. Within each division, runners ... their physical limit - for a worthy cause. All ...
Breaking Medicine News(10 mins):Health News:Carey Danis & Lowe Reports On New Court Order in C.R. Bard Transvaginal Mesh MDL 2Health News:BambooIndustry.com: Cheap Bamboo Panels for Clients Worldwide Offered Online 2Health News:Reliable Supplier Delta Adds New Items To Its Used Bulldozer Collection 2Health News:C2 Survival Racers Go to Extremes to Provide Kids with YMCA Programs 2
... , , ... , ... , , , ... ...
... ... ... ... ...
... has studied the international research alliance the Multilateral Initiative ... general and the strengthening of research environments in Africa. ... in areas outside Africa. This has led to a ... problems that dominate everyday life in those areas where ...
... ... iTouch. The innovative torque application is the first of its kind. , ... San Diego, CA (PRWEB) February 22, 2010 -- Flexible Assembly ... iTouch. The innovative torque application is the first of its kind and is free for ...
... , ... Shield of Texas has designated Houston Northwest Medical Center as a Blue Distinction Center for ... Houston, TX ... Northwest Medical Center as a Blue Distinction Center for Spine Surgery. Blue Distinction Centers for ...
... ... ... ... ...
Cached Medicine News:Health News:Statewide Poll: Pennsylvania Must Adequately Fund Senior Care Services 2Health News:Statewide Poll: Pennsylvania Must Adequately Fund Senior Care Services 3Health News:Remuda Ranch Programs for Eating and Anxiety Disorders Sponsors a Special Edition of the Award-Winning Documentary America The Beautiful 2Health News:Remuda Ranch Programs for Eating and Anxiety Disorders Sponsors a Special Edition of the Award-Winning Documentary America The Beautiful 3Health News:Remuda Ranch Programs for Eating and Anxiety Disorders Sponsors a Special Edition of the Award-Winning Documentary America The Beautiful 4Health News:Remuda Ranch Programs for Eating and Anxiety Disorders Sponsors a Special Edition of the Award-Winning Documentary America The Beautiful 5Health News:Malaria research must be based in Africa 2Health News:Flexible Assembly Systems Announces New Torque Calculator App for the iPhone 2Health News:Houston Northwest Medical Center Has Been Designated as a Blue Distinction Center for Spine Surgery 2Health News:Houston Northwest Medical Center Has Been Designated as a Blue Distinction Center for Spine Surgery 3Health News:Houston Northwest Medical Center Has Been Designated as a Blue Distinction Center for Spine Surgery 4Health News:AppDynamics Announces General Availability of AppDynamics v2.0 2Health News:AppDynamics Announces General Availability of AppDynamics v2.0 3Health News:AppDynamics Announces General Availability of AppDynamics v2.0 4Health News:AppDynamics Announces General Availability of AppDynamics v2.0 5Health News:AppDynamics Announces General Availability of AppDynamics v2.0 6Health News:AppDynamics Announces General Availability of AppDynamics v2.0 7Health News:AppDynamics Announces General Availability of AppDynamics v2.0 8Health News:AppDynamics Announces General Availability of AppDynamics v2.0 9
... MaximEyes by First Insight is the ... records solution for eye care professionals. ... with Eyefinitys online servicesrequest VSP authorizations, ... MaximEyes offers EMR, scheduling, billing, demographics, ...
... software- RLISYS provides a ... Support, and Training exclusively ... Ophthalmology, and Opticianry- The ... allowing you to focus ...
... The Advia 120 hematology ... streamline laboratory workflow and ... This analyzer offers a ... assays, meeting the needs ...
The K-4500 automated hematology analyzer offers fast reliable test results of 18-parameter plus 3-histograms, valuable for effective diagnosis....
Medicine Products: